Skip to main content
Premium Trial:

Request an Annual Quote

Celera Expects to Become Profitable in June

NEW YORK, Oct. 8 - Celera Genomics' online database business will become profitable by the end of June 2002, Chief Business Officer Peter Barrett told an investor conference here on Monday.

He added that Celera’s acquisition of Axys Pharmaceuticals, announced in June 2001, is expected to close during the current quarter.

Speaking at the UBS Warburg Global Life Sciences Conference, which runs through the end of the week, Barrett said that the 3-year-old company has about $1 billion in the bank and isn’t averse to dipping into that reserve to help it evolve into a biopharmaceutical firm based on diagnostics and drug discovery.

Celera's acquisition of Axys is believed to help with that effort.

Tony White, CEO of Applera, Celera’s parent company, said at the conference that while the company “is concerned about cash burn, we’re not talking about burning down the house.” 

“We’re in a pretty good position,” White added. But “the preservation of this asset [cash on hand] is important.”

The company plans to issue financial results of the first quarter, which ended on Sept. 30, later this month.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.